Barclays’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-251,154
| Closed | -$18.6M | – | 4280 |
|
|
2015
Q3 | $18.6M | Sell |
251,154
-13,909
| -5% | -$1.03M | 0.02% | 328 |
|
|
2015
Q2 | $19.9M | Buy |
265,063
+256,342
| +2,939% | +$19.2M | 0.02% | 364 |
|
|
2015
Q1 | $437K | Buy |
8,721
+2,442
| +39% | +$122K | ﹤0.01% | 1983 |
|
|
2014
Q4 | $213K | Buy |
6,279
+1,127
| +22% | +$38.2K | ﹤0.01% | 2340 |
|
|
2014
Q3 | $165K | Buy |
5,152
+248
| +5% | +$7.94K | ﹤0.01% | 2404 |
|
|
2014
Q2 | $186K | Buy |
4,904
+1,874
| +62% | +$71.1K | ﹤0.01% | 2430 |
|
|
2014
Q1 | $118K | Buy |
3,030
+1,090
| +56% | +$42.4K | ﹤0.01% | 2682 |
|
|
2013
Q4 | $71K | Buy |
1,940
+1,556
| +405% | +$56.9K | ﹤0.01% | 3223 |
|
|
2013
Q3 | $17K | Sell |
384
-147
| -28% | -$6.51K | ﹤0.01% | 3536 |
|
|
2013
Q2 | $14K | Buy |
+531
| New | +$14K | ﹤0.01% | 3813 |
|